Ann: A World First for MCL in Autoimmune Disease Reasearch, page-52

Your view is reasonable for a short term holder, but is the opposite to mine. Others with short term views may have sold out today putting some downward pressure on the SP. I do not expect the effect on the SP will last very long. Today's Ann is very positive for the future of MCL in the medical space, and puts QBL into a similar type of investment space as ZLD.
As far as spending the $3 mill. in a better area, I disagree. Remember it is spread over 3 years.